That means translating complex clinical evidence into accessible health information across the website, clinical pathways and media communications
Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members
In one study, participants took an average of about 66 days to form a habit, though some habits developed more quickly and others took several months
Potential Side Effects and Risks of GLP-1 RAs Whilst highly effective, GLP-1 receptor agonists are not without side effects
Address cost head-on by offering transparent cash-pay options, affordability programs, and payer partnerships
Retatrutide's higher weight-loss ceiling exists because glucagon receptor agonism adds a second, parallel fat-loss pathway that tirzepatide and semaglutide do not engage